ATRenew (RERE) Cash & Equivalents (2019 - 2026)

ATRenew has disclosed Cash & Equivalents across 8 years of filings, most recently posting $146.8 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $146.8 million, down 41.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $146.8 million (down 41.12% YoY), and the FY2025 annual result was $219.9 million, down 18.55% from the prior year.
• Cash & Equivalents came in at $146.8 million for Q1 2026 at ATRenew, down from $216.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $274.8 million in Q4 2023 to a low of $146.8 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $216.8 million (2025), against an average of $213.0 million.
• Across the five-year window, Cash & Equivalents tumbled 57.92% in 2022 and gained 28.29% in 2023, its largest moves.
• ATRenew's Cash & Equivalents stood at $239.5 million in 2022, then advanced by 14.73% to $274.8 million in 2023, then dropped by 0.19% to $274.3 million in 2024, then slipped by 20.97% to $216.8 million in 2025, then sank by 32.28% to $146.8 million in 2026.
• The last three Cash & Equivalents figures came in at $146.8 million (Q1 2026), $216.8 million (Q4 2025), and $228.6 million (Q3 2025), per Business Quant data.